Mark Zupancic

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 29, 2025
Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022.

Anders Näsman, Madeleine Birgersson, Tobias Näsman

|Apr 26, 2024
Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer.

Lars Sivars, Cecilia Jylhä, Ylva Crona Guterstam

|Apr 13, 2023
High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma.

Caroline Haglund de Flon, Linnea Haeggblom, Stefan Holzhauser

|Mar 11, 2023
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort.

Mark Zupancic, Anders Näsman, Anders Berglund

|Jan 08, 2023
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited.

Karin Byskata, Monika Lukoseviciute, Filippo Tuti

|Jul 27, 2022
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.

Ourania N Kostopoulou, Mark Zupancic, Mariona Pont

Pageof 1

Frequent Collaborators

3 joint publications

Anders Näsman

1 joint publications

Mariona Pont

1 joint publications

Filippo Tuti

1 joint publications

Signe Friesland